November 02, 2026 at 12:50 PM UTC
Valion Bio, Inc. reports leadership or board changes
Valion Bio, Inc. filed an 8-K covering director or executive-officer changes and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 02, 2026 at 12:50 PM UTC
Open official source